Prospective longitudinal follow-up of children with sickle cell disease treated with hydroxyurea since infancy

Ronay Thomas1, Robin Dulman1,2, Angela Lewis1

  • 1Department of Hematology-Oncology, Pediatric Specialists of Virginia, Falls Church, Virginia.

Insights

Hydroxyurea (HU) is safe and effective for infants with sickle cell disease (SCD). Early HU treatment in infancy significantly reduces SCD complications, making community practice implementation feasible.

Area of Science:

  • Pediatric Hematology
  • Sickle Cell Disease Management
  • Pharmacological Interventions

Background:

  • Hydroxyurea (HU) is known to increase fetal hemoglobin (HgbF) and alleviate symptoms in sickle cell disease (SCD).
  • Existing studies confirm the safety and efficacy of HU in pediatric populations.
  • There is a need to integrate HU initiation into routine community healthcare for infants with SCD.

Purpose of the Study:

  • To evaluate the feasibility and effectiveness of initiating Hydroxyurea (HU) therapy in infants diagnosed with sickle cell disease (SCD).
  • To assess the impact of early HU intervention on disease complications and clinical outcomes in young children with SCD.

Main Methods:

  • A prospective longitudinal study was conducted, tracking 24 infants with HgbSS who began HU treatment before age one.
  • Data on clinical course and outcomes were collected over 95 person-years of follow-up.
  • Outcomes included hemoglobin levels, HgbF percentages, hospitalizations, emergency department visits, and specific SCD complications.

Main Results:

  • Infants receiving HU by age one showed sustained increases in hemoglobin and HgbF levels.
  • A significant reduction in hospitalizations and emergency department visits for SCD-related complications was observed after HU initiation.
  • No cases of acute chest syndrome, abnormal transcranial Doppler findings, or strokes occurred; pain episodes requiring medical attention were eliminated.

Conclusions:

  • Initiating Hydroxyurea (HU) therapy in infancy for children with sickle cell disease (SCD) is a feasible strategy for community practice.
  • Early HU treatment is highly effective in preventing serious disease complications, improving the clinical course of SCD in early childhood.
Abstract

Related Concept Videos

Socioemotional Development during Infancy01:30

Socioemotional Development during Infancy

Socio-emotional development in infancy is primarily shaped by early emotional responses and social connections, with temperament playing a central role. Temperament refers to the consistent patterns in an individual's emotional and behavioral responses, observable even in infancy. By examining temperament, researchers can better understand an infant's unique ways of interacting with the world, influencing subsequent personality and socio-emotional growth.
Primary Temperament Types
440
Longitudinal Research02:20

Longitudinal Research

Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
13.2K
Longitudinal Studies01:26

Longitudinal Studies

Longitudinal studies are also widely used in other medical and social science fields. For instance, in cardiovascular research, they can monitor patients' health over decades to identify risk factors for heart disease, such as high cholesterol or smoking, and evaluate the long-term effectiveness of preventive measures. Similarly, in mental health studies, researchers might follow individuals from adolescence into adulthood to understand the development and progression of conditions like...
487
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
265
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.4K
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
989